Past exam of the systems biology course of the University of Cambridge / 2024 / Paper 4 / Section II / 2.1 / Solution

Central hypothesis and objectives. PUF50 participates in one or more protein assemblies whose composition or activity affects Wnt signalling. The proposal should distinguish membership, direct binding and causal pathway regulation. The three aims are to nominate plausible partners, identify reproducible cellular complexes, and test whether a supported interaction explains the phenotype.

Computational starting point. Inspect the verified PUF50 sequence for protein domains, localization signals, conserved residues and predicted disordered regions. Use sequence alignment and orthology to compare well-annotated homologues, recording uncertainty in functional transfer. Public interaction and expression resources can nominate partners expressed in the experimental cell line. Structural predictions can prioritize testable interfaces, but a confident fold alone does not establish a cellular interaction or tumour-suppressor function.

Discovery proteomics. Use affinity purification-mass spectrometry to compare PUF50-associated material with matched negative controls across independent biological replicates. An endogenous or functionally validated tagged preparation is preferable to assuming that strong overexpression preserves normal localization and complex stoichiometry. Tag-only controls, input abundance measurements and an unrelated bait help distinguish reproducible association from abundant or sticky contaminants. Quantitative enrichment should be evaluated together with replicate consistency and a controlled false discovery rate.

Complexes may vary with pathway state. Compare a relevant baseline and a defined Wnt-responsive state, checking that changes in recovered partner abundance are not explained solely by input abundance, cell number or viability. If transient or compartmentalized partners are missed, proximity labeling can provide complementary neighbourhood evidence. Its hits should be labelled as proximity associations rather than automatically promoted to direct complex subunits.

Independent validation and mechanism. Validate leading associations by reciprocal co-immunoprecipitation and localization evidence. Where a direct interaction is important to the proposed mechanism, test it with an independent assay suited to the relevant protein domains. A genetic perturbation and rescue comparison can ask whether loss of PUF50 changes pathway output and whether restoring PUF50 restores it. Compare pathway-proximal measurements with downstream transcription and longer-term growth phenotypes, because a growth defect alone is not specific to Wnt regulation.

A separation-of-function comparison is especially informative: a PUF50 variant that retains abundance and localization but loses a supported partner association could help connect the interaction to function. This interpretation requires checking folding and stability, since an inactive misfolded protein does not isolate one interface's role. Genetic interaction analysis can then place PUF50 relative to known pathway components without treating every correlated expression change as a direct target.

Analysis, deliverables and alternatives. Integrate quantitative interaction evidence, localization and perturbation responses into an annotated protein interaction network, retaining evidence type on each edge. Report effect sizes and uncertainty, include unsuccessful validation, and release analysis code with processed data. A negative stable-complex result would motivate a transient or condition-specific interaction hypothesis rather than proving that PUF50 acts alone. The principal deliverable is a ranked, experimentally qualified set of complexes and a causal test of the most supported pathway mechanism.